Intravenous Enzyme Replacement Therapy for Fabry Disease
The HSE wishes to establish a new national multi-supplier contract for the provision of Intravenous Enzyme Replacement Therapy (ERT) for Fabry Disease. The contract will support the delivery of ERT treatment to patients in either a hospital setting or in their own home. The scope of the contract includes the supply of medication to hospitals and to patients in a home setting and also the provision of infusion accessories and a nursing service for the administration of ERT to patients at home.
The HSE is now seeking Expressions of Interest from Providers who wish to be considered by the HSE for this contract.
For full details please see the Expression of Interest documentation, available to download from the etenders site (
http://www.etenders.gov.ie).
Deadline
The time limit for receipt of tenders was 2018-05-28.
The procurement was published on 2018-04-26.
Who?
What?
Where?
Procurement history
| Date |
Document |
| 2018-04-26
|
Contract notice
|